Skip to main content
. 2014 Apr 3;2014(4):CD006531. doi: 10.1002/14651858.CD006531.pub2

Comparison 83. SE ‐ Sweating.

Outcome or subgroup title No. of studies No. of participants Statistical method Effect size
1 Paroxetine versus older ADs 15 2970 Odds Ratio (M‐H, Random, 95% CI) 0.75 [0.50, 1.12]
1.1 versus amitriptyline 5 774 Odds Ratio (M‐H, Random, 95% CI) 1.72 [0.60, 4.90]
1.2 versus clomipramine 2 1111 Odds Ratio (M‐H, Random, 95% CI) 0.73 [0.48, 1.10]
1.3 versus imipramine 6 681 Odds Ratio (M‐H, Random, 95% CI) 0.43 [0.29, 0.65]
1.4 versus lofepramine 1 106 Odds Ratio (M‐H, Random, 95% CI) 0.13 [0.01, 1.10]
1.5 versus maprotiline 1 298 Odds Ratio (M‐H, Random, 95% CI) 1.51 [0.77, 2.96]
2 Paroxetine versus other SSRIs 8   Odds Ratio (M‐H, Random, 95% CI) Subtotals only
2.1 versus escitalopram 1 454 Odds Ratio (M‐H, Random, 95% CI) 1.49 [0.81, 2.72]
2.2 versus fluoxetine 6 1431 Odds Ratio (M‐H, Random, 95% CI) 0.95 [0.43, 2.12]
2.3 versus fluvoxamine 1 60 Odds Ratio (M‐H, Random, 95% CI) 4.5 [1.09, 18.50]
3 Paroxetine versus newer or non‐conventional ADs 18   Odds Ratio (M‐H, Random, 95% CI) Subtotals only
3.1 versus aprepitant (MK‐869) 1 143 Odds Ratio (M‐H, Random, 95% CI) 4.31 [0.88, 21.07]
3.2 versus bupropion 1 140 Odds Ratio (M‐H, Random, 95% CI) 1.36 [0.53, 3.46]
3.3 versus duloxetine 5 1573 Odds Ratio (M‐H, Random, 95% CI) 0.80 [0.50, 1.28]
3.4 versus hypericum 1 251 Odds Ratio (M‐H, Random, 95% CI) 1.48 [0.61, 3.61]
3.5 versus mirtazapine 3 726 Odds Ratio (M‐H, Random, 95% CI) 3.12 [1.61, 6.03]
3.6 versus nefazodone 1 40 Odds Ratio (M‐H, Random, 95% CI) 22.78 [1.20, 432.58]
3.7 versus reboxetine 3 1375 Odds Ratio (M‐H, Random, 95% CI) 0.48 [0.34, 0.68]
3.8 versus tianeptine 1 277 Odds Ratio (M‐H, Random, 95% CI) 13.49 [0.75, 241.76]
3.9 versus trazodone 1 108 Odds Ratio (M‐H, Random, 95% CI) 3.17 [0.13, 79.60]
3.10 versus venlafaxine 1 361 Odds Ratio (M‐H, Random, 95% CI) 2.95 [0.92, 9.44]